Industry / innovation partners

CAR-T Starts Moving From Factory Medicine to In-Patient Engineering

Cellular Reprogramming Enters Neuro-Ophthalmology

Screwworm Turns Pet Treatment Into a One Health Preparedness Issue

Chronic pain may be a cardiovascular warning sign, not just a symptom

ALS Survival Data Return to the Evidence Debate

Could AI help prevent the next athlete cardiac tragedy? Evidence is moving faster than practice

Sanofi’s Tzield moves type 1 diabetes into disease modification, but access may decide who benefits

WHO is preparing to ration the obesity drug revolution before it becomes another access disaster

CAR-T Starts Moving From Factory Medicine to In-Patient Engineering
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
